Prognostic value and therapeutic consequences of vascular invasion in non-small cell lung carcinoma

Lung Cancer

Volumn 64, Issue 1, 2009, Pages 71-78

  Bodendorf, Marc Oliver ^a   Haas, Victor ^b   Laberke, Hans Gerd ^a   Blumenstock, Gunnar ^c   Wex, Peter ^b   Graeter, Thomas ^b  

^a Institute of Pathology   (Germany)

^b Department of Thoracic and Vascular Surgery ^*  (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Biology; Histology; Lung cancer; Pathology; Surgery; Vascular invasion

Indexed keywords

ADRENAL CANCER; ADULT; AGED; ARTICLE; BLOOD VESSEL; BONE METASTASIS; BRAIN METASTASIS; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL DECISION MAKING; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; KAPLAN MEIER METHOD; LIVER CANCER; LUNG ADENOCARCINOMA; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURGICAL APPROACH; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PNEUMONECTOMY; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 61749103950     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.07.011     Document Type: Article

References (44)

1. Becker H.D., Hohenberger W., Junginger T., and Schlag P.M. Chirurgische Onkologie (2002), Thieme, Stuttgart/New York
2. Colby T.V., Koss M.N., and Travis W.D. Atlas of tumor pathology. Fasc. 13. Tumors of the lower respiratory tract (1995), Armed Forces Institute of Pathology, Washington, DC p. 1-286
3. Drings P., Hasse J., Hermanek P., and Wagner G. Klassifikation maligner Thoraxtumoren. Lunge, Pleura, Mediastinum (2003), Springer, Berlin/Heidelberg/New York/London/Mailand/Paris/Tokyo
4. Naruke T., Tsuchiya R., Kondo H., and Asamura H. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience. Ann Thorac Surg 71 (2001) 1759-1764
5. Präuer H.W., Müller C., and Thetter O. Operative Behandlung des Bronchialkarzinoms. Tumoren der Lunge und des Mediastinums (2003), Zuckschwerdt, Tumorzentrum München
6. Gajra A., Newman N., Gamble G.P., Kohman L.J., and Graziano S.L. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol 21 (2003) 1029-1034
7. Kessler R., Gasser B., Massard G., Roeslin N., Meyer P., Wihlm J.M., et al. Blood vessel invasion is a major prognostic factor in resected non-small cell lung cancer. Ann Thorac Surg 62 (1996) 1489-1493
8. Liptay M.J., Masters G.A., and Winchester D.J. Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer. Ann Thorac Surg 70 (2000) 384-390
9. Osaki T., Nagashima A., Yoshimatsu T., Tashima Y., and Yasumoto K. Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer. Lung Cancer 43 (2003) 151-157
10. Schultheis K.H., Baumann M., Meyer W., Gebhardt C., Mittelmeier H.O., and Wünsch P. Lymph- und Haemangiosis carcinomatosa - ein wichtiger Prognosefaktor beim nicht-kleinzelligen Bronchialkarzinom (NSCLC). Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir 113 (1996) 775-778
11. Suzuki K., Nagai K., and Yoshida J. Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma. A comparison of prognostic factors for each pathologic TNM stage based on multivariate analyses. Cancer 86 (1999) 1976-1984
12. Corrin B. Pathology of the lungs (2000), Churchill Livingstone, London/Edinburgh/New York/Philadelphia/Sydney/St. Louis/Toronto
13. Drings P. Significance of TNM-system in medical oncology. J Cancer Res Clin Oncol 128 (2002) 1
14. Hermanek P., and Bülzebruck H. Staging des Lungenkarzinoms. In: Drings P., and Vogt-Moykopf I. (Eds). Thoraxtumoren. Diagnostik-Staging-Gegenwärtiges Therapiekonzept. 2nd ed. (1998), Springer, Berlin/Heidelberg/New York/Tokyo
15. Bréchot J.M., Chevret S., Charpentier M.C., Appere de Vecchi C., Capron F., Prudent J., et al. Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma. Correlation with TNM stage and disease free and overall survival. Cancer 78 (1996) 2111-2118
16. Bodendorf M. Lymphangiosis und Haemangiosis carcinomatosa bei 112 Operationsfällen von nichtkleinzelligen Lungenkarzinomen im Frühstadium der lymphogenen Metastasierung: Morphologie, klinischer Verlauf und Prognose. Germany: Dissertation University of Tuebingen; 2005.
17. Naruke T., Suemasu K., and Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 76 (1978) 832-839
18. Travis W.D., Brambilla E., Müller-Hermelink H.K., and Harris C.C. WHO Classification of tumours. Pathology and genetics. Tumours of the lung, pleura, thymus and heart (2004), IARC Press, Lyon
19. Wittekind C., Meyer H.J., and Bootz F. TNM-Klassifikation maligner Tumoren. 6th ed. (2002), Springer, Berlin/Heidelberg/New York/Barcelona/Hong Kong/London/Mailand/Paris/Tokyo
20. Ziegler A., Lange S., and Bender R. Überlebenszeitanalyse: Eigenschaften und Kaplan-Meier Methode. Dtsch Med Wschr 127 (2002) 14-16
21. Ziegler A., Lange S., and Bender R. Überlebenszeitsanalyse: Der Log-Rang-Test. Dtsch Med Wschr 129 (2004) 4-6
22. Lange S., and Bender R. Was ist ein Signifikanztest? Allgemeine Aspekte. Dtsch Med Wschr 126 (2001) 42-44
23. Tosi P., Luzi P., Leoncini L., Miracco C., Gambacorta M., and Gross A. Bronchogenic carcinoma: survival after surgical treatment according to stage, histologic type and immunomorphologic changes in regional lymph nodes. Cancer 48 (1981) 2288-2295
24. In: Cagle P.T., Allen T.C., Barrios R., Bedrossian C., Haque A.K., Laga A.C., et al. (Eds). Pulmonary pathology (2005), Lippincott Williams and Wilkins, Philadelphia/Baltimore/New York/London/Buenos Aires/Hong Kong/Sydney/Tokyo
25. Dail D.H., and Hammar S.P. Pulmonary pathology. 2nd ed. (1994), Springer, New York/Berlin/Heidelberg/London/Paris/Tokyo/Hong Kong/Barcelona/Budapest
26. Gabor S., Renner H., Popper H., Anegg U., Sankin O., Matzi V., et al. Invasion of blood vessels as significant prognostic factor in radically resected T1-3 N0M0 non-small-cell-lung cancer. Eur J Cardiothorac Surg 25 (2004) 439-442
27. Khan O.A., Fitzgerald J.J., Field M.L., Soomro I., Beggs F.D., Morgan W.E., et al. Histological determinants of survival in completely resected T1-2N1MO nonsmall cell cancer of the lung. Ann Thorac Surg 77 (2004) 1173-1178
28. Mineo T.C., Ambrogi V., Baldi A., Rabitti C., Bollero P., Vincenzi B., et al. Prognostic impact of VEGF, CD31, CD 34, and CD 105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer. J Clin Pathol 57 (2004) 591-597
29. Macchiarini P., Fontanini G., and Hardin M.J. Blood vessel invasion by tumor cells predicts recurrence in completely resected T1N0M0 non-small-cell lung cancer. J Thorac Cardiovasc Surg 106 (1993) 80-89
30. Martini N., Flehinger B.J., Nagasaki F., and Hart B. Prognostic significance of N1 disease in carcinoma of the lung. J Thorac Cardiovasc Surg 86 (1983) 646-653
31. Luzzi L., Voltolini L., and Campion A. Pneumonectomy vs lobectomy in the treatment of pathologic N1 NSCLC: could the type of surgical resection dictate survival?. J Cardiovasc Surg 44 (2003) 119-123
32. Asamura H., Suzuki K., Kondo H., and Tsuchiya R. Where is the boundary between N1 and N2 stations in lung cancer?. Ann Thorac Surg 70 (2000) 1839-1846
33. Funai K., Yokose T., and Ishii G.I. Clinicopathologic characteristics of peripheral squamous cell carcinoma of the lung. Am J Surg Pathol 27 (2003) 978-984
34. Terasaki H., Niki T., and Matsuno Y. Lung adenocarcinoma with mixed bronchioloalveolar and invasive components. Clinicopathological features, subclassification by extent of invasive foci, and immunohistochemical characterization. Am J Surg Pathol 27 (2003) 937-951
35. Collier F.C., Enterline H.T., Kyle R.H., Tristan T.T., and Greening R. The prognostic implications of vascular invasion in primary carcinomas of the lung. Am Arch Pathol 66 (1958) 594-603
36. Harpole D.H., Herndon J.E., Wolfe W.G., Iglehart J.D., and Marks J.R. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. Cancer Res 55 (1995) 51-56
37. Ichinose Y., Yano T., Asoh H., Yokoyama H., Yoshino I., and Katsuda Y. Prognostic factors obtained by a pathologic examination in completely resected non-small-cell lung cancer. An analysis in each pathologic stage. J Thorac Cardiovasc Surg 110 (1995) 601-605
38. Baird J.A. The pathways of lymphatic spread of carcinoma of the lung. Br J Surg 52 (1965) 868-875
39. Croxatto O.C., and Barcat J.A. Lymph node metastasis in bronchogenic carcinoma. Study on its role in dissemination. Hopkins Med J 126 (1969) 121-129
40. Huwer H., Volkmer I., Hülsewede R., and Hausinger F. A contribution on the prognostic significance of the tumor formula (pTNM) in squamous cell carcinoma of the bronchus. J Thorac Cardiovasc Surg 37 (1989) 281-284
41. Roberts T.E., Hasleton P.S., Musgrove C., Swindell R., and Lawson R.A. Vascular invasion in non-small cell lung carcinoma. J Clin Pathol 45 (1992) 591-593
42. Strauss GM, Hernton J, Maddaus MA, Johnstone DW, Johnson EA, Watson DM, et al. Report of Cancer and Leukemia Group B (CALGB) Protocol 9633, USA, ASCO 2004, Abstract 7019.
43. Tsuchiya T., Akamine S., Muraoka M., Kamohara R., Tsuji K., Urabe S., et al. Stage IA non-small cell lung cancer: Vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy. Lung Cancer 56 (2007) 341-348
44. Winton TL, Livingston R, Johnson D. JBR. 10-Studie. National Cancer Institute of Canada, Kingston, ASCO 2004, Abstract 7018.